United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r) - ​for temporary relief of blurred vision, mental sluggishness, mood swings, gas, headaches, chest congestion, aspartame sensitivity, hypertension, seasonal affective disorder, sleep disorders, food sensitivities, depression and poor appetite.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of blurred vision, mental sluggishness, mood swings, gas, headaches, chest congestion, aspartame sensitivity, hypertension, seasonal affective disorder, sleep disorders, food sensitivities, depression and poor appetite.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - l-phenylalanine 4x, 7x, 12x - for the temporary relief of minor muscle or joint pain or inflammation, sadness, irritability, restlessness, or poor concentration.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - phenylalanine 9x, 12x, 30x, 60x - for the temporary relief of occasional headache, congestion, or lethargy due to sensitivity to phenolic compounds found in foods or other products.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

New Zealand - English - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - methylphenidate hydrochloride 36mg (drug layer 1, drug layer 2 & drug coat) - modified release tablet - 36 mg - active: methylphenidate hydrochloride 36mg (drug layer 1, drug layer 2 & drug coat) excipient: butylated hydroxytoluene carnauba wax cellulose acetate hypromellose ferric oxide, green (push layer) iron oxide yellow opacode black ns-78-17715 opadry clear ys-1-19025-a opadry white y-30-18037 phosphoric acid poloxamer 188 polyethylene oxide povidone sodium chloride stearic acid succinic acid - concerta is indicated for the treatment of attention deficit hyperactivity disorder (adhd). a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. need for comprehensive treatment programme: concerta is indicated as an integral part of a total treatment program for adhd that may include other measures (psychological, educational and social) for patients with this syndrome. stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. appropriate educational placement is essential and psychosocial intervention is often helpful. when remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the patient's symptoms. long term use: the effectiveness of concerta for long-term use has not been systematically evaluated in controlled trials. therefore the physician who elects to use concerta for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Israel - English - Ministry of Health

medison pharma ltd - pasireotide as diaspartate - solution for injection - pasireotide as diaspartate 0.6 mg/ml - pasireotide - pasireotide - treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - methylphenidate 31.13mg eqv methylphenidate hcl - tablet, film coated - 36mg - methylphenidate 31.13mg eqv methylphenidate hcl 36mg

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - mercaptopurine 20 mg/ml - oral suspension - 20 mg/ml - active: mercaptopurine 20 mg/ml excipient: aspartame potassium sorbate purified water raspberry flavour - concentrated juice (nova) sodium ethyl hydroxybenzoate sodium hydroxide sodium methyl hydroxybenzoate xanthan gum - allmercap is indicated for the treatment of acute lymphoblastic leukaemia (all) in paediatric patients.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), quercetin (unii: 9ikm0i5t1e) (quercetin - unii:9ikm0i5t1e), rutin (unii: 5g06tvy3r7) (rutin - unii:5g06tvy3r7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ferric chloride hexahydrate (unii: 0i2xin602u) (ferric cation - unii:91o4lml611), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), ferrous sulfate (unii: 39r4tan1vt) ( - phenylalanine 6 [hp_x] in 1 ml - temporary relief of symptoms related to iron in foods and supplements, including fatigue, cramping and jitteriness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to iron in foods and supplements, including fatigue, cramping and jitteriness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), taurine (unii: 1eqv5mly3d) (taurine - unii:1eqv5mly3d), sus scrofa nerve (unii: jxv50i6zhk) (sus scrofa nerve - unii:jxv50i6zhk), adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sus scrofa cerebrum (unii: 4gb5dqr532) (sus scrofa cerebrum - unii:4gb5dqr532), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9f - phenylalanine 6 [hp_x] in 1 ml - temporary relief of symptoms related to blocked energy in the body including fatigue, temperature fluctuations, cramping and nervousness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to blocked energy in the body including fatigue, temperature fluctuations, cramping and nervousness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lamberts healthcare ltd - l-phenylalanine - oral capsule - 500mg